摘要
目的探讨鹿血晶治疗恶性肿瘤放化疗所致血小板减少症的临床效果。方法选择2019年1月—2020年12月赣南医学院第一附属医院收治的恶性肿瘤放化疗所致血小板减少症患者75例,采用随机数字表法分为3组,每组各25例。对照组使用rhlL-11治疗,试验组1使用鹿血晶治疗,试验组2采用rhlL-11联合鹿血晶治疗。比较3组治疗效果、血小板计数及不良反应。结果试验组2治疗总有效率(96.00%)高于试验组1(68.00%)、对照组(64.00%),差异有统计学意义(P<0.05);治疗后,3组血小板计数均升高,且试验组2>试验组1>对照组,差异有统计学意义(P<0.05);3组不良反应发生率相比,差异无统计学意义(P>0.05)。结论恶性肿瘤放化疗所致血小板减少症患者采用鹿血晶联合rhlL-11治疗效果优于单药治疗,利于提高疗效,改善血小板计数,且不良反应较少,值得推广。
Objective To investigate the clinical effect of Lu Xuejing in treating thrombocytopenia caused by radiotherapy and chemotherapy in malignant tumor. Methods From January 2019 to December 2020,75 patients with thrombocytopenia caused by radiotherapy and chemotherapy were selected, Using the random number table method, Each group was 25 cases. Control group treated with rhlL-11, The experimental group was treated with deer blood crystal,Experimental group 2 was treated with rhlL-11 and deer blood crystal. The therapeutic effect, platelet count and adverse reactions were compared between the three groups. Results The total effective rate(96.00%)in experimental group Ⅱ was higher than that in experimental group Ⅰ(68.00%) and control group(64.00%), difference was statistically significant(P<0.05);After treatment, All three groups had elevated platelet counts, The experimental group > the experimental group > the control group, difference was statistically significant(P<0.05);Compared with the incidence of adverse reactions in the three groups, and the difference was not statistically significant(P>0.05).Conclusion The treatment of thrombocytopenia caused by radiotherapy and chemotherapy in malignant tumor is better than that rhlL-11 single drug, to improve the treatment, improved platelet count, and less adverse reactions, It is worth popularizing and applying.
作者
廖家华
张小军
衷敬华
许明君
Liao Jiahua;Zhang Xiaojun;Zhong Jinghua(The First Affiliated Hospital of Gannan Medical College,Ganzhou Jianxgi341000)
出处
《基层医学论坛》
2021年第31期4441-4443,共3页
The Medical Forum
基金
江西省卫生计生委中医药科研课题(2015A138)。
关键词
恶性肿瘤
放化疗
血小板减少症
鹿血晶
Malignant neoplasm
Radiotherapy and chemotherapy
Thrombocytopenia
Lu xuejing
